Volume 8 Issue 124
Published - 14:00 UTC 08:00 EST 4-May-2006 
Next Update - 14:00 UTC 08:00 EST 5-May-2006

Editor: Susan K. Boyer, RN
All rights reserved.

HONcode accreditation seal. We subscribe to the HONcode principles.
Verify here



FDA approves new treatment for myelodysplastic syndromes (MDS)

The Food and Drug Administration (FDA) approved Dacogen (decitabine) injection for the treatment of myelodysplastic syndromes (MDS). Dacogen is a new molecular entity that received orphan drug status. Orphan products are developed to treat rare diseases or conditions that affect fewer than 200,000 people in the U.S. The Orphan Drug Act provides a seven-year period of exclusive marketing to the first sponsor who obtains marketing approval for a designated orphan drug. more  

By combining different CT views, radiologists can better evaluate the GI tract

Combined evaluation of transverse images--horizontal slices of a standing body--and multiplanar coronal reformats--vertical slices from head to foot--from CT scans give radiologists more information about the GI tract to better diagnose problems, according to a new study by researchers from Emory University School of Medicine in Atlanta, GA. more

Near 100 percent mammagraphy recall compliance costs less than a quarter per patient

The hidden costs of achieving a 99.5% mammography recall compliance rate is 16 cents per screening patient, according to a recent study administered by the radiology department at the University of Michigan in Ann Arbor, MI. more  

Patients have high expectations about screening mammography

A substantial proportion of women have beliefs about their personal risk of breast cancer, and expectations about the performance of mammography that are abnormally high or unrealistic, according to a survey conducted at University of Michigan Health Systems in Ann Arbor, Michigan. more

Italian researchers find fenretinide cuts the risk of second breast cancers in young women 

A 15-year follow-up of women in a breast cancer trial has found that fenretinide a drug related to vitamin A significantly cuts the risk of a second breast cancer among younger patients. more

The brain's motivation station  

The prospect of a paycheck, good grade, or promotion wonderfully concentrates the mind, and researchers have now identified the brain circuitry responsible for such reward-motivated learning. more

Patients with nonalcoholic fatty liver disease have an increased risk of heart disease

A new study on the relationship between nonalcoholic fatty liver disease (NAFLD) and heart disease found that patients with an elevated level of the enzyme associated with NAFLD had an increased risk of coronary heart disease, which appears to be related to insulin resistance, obesity and central fat distribution. more


Many women have expectations about the performance of mammography that are abnormally high or unrealistic.